Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Hanke

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Journal of Medicinal Chemistry|July 2, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Small-molecule modulators of HIPK4 activity and proteostasisZaile Zhuang, Riley K Togashi, Patrick Kearney, et al.
ACS Chemical Biology|May 1, 2026
Discovery and Development of a Potent LIMK2 Isoform-Specific DegraderKamal Rayees Abdul Azeez, Hayuningbudi Saraswati, Thorsten Mosler, et al.
Journal of Hematology & Oncology|December 19, 2024
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Journal of Hematology & Oncology|January 25, 2025
Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Nature Communications|November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsMartin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
Cell Chemical Biology|November 28, 2017
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target EngagementJames D Vasta, Cesear R Corona, Jennifer Wilkinson, et al.
Elife|April 21, 2018
Donated chemical probes for open scienceSusanne Müller, Suzanne Ackloo, Cheryl H Arrowsmith, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Journal of Medicinal Chemistry|July 2, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Small-molecule modulators of HIPK4 activity and proteostasisZaile Zhuang, Riley K Togashi, Patrick Kearney, et al.
ACS Chemical Biology|May 1, 2026
Discovery and Development of a Potent LIMK2 Isoform-Specific DegraderKamal Rayees Abdul Azeez, Hayuningbudi Saraswati, Thorsten Mosler, et al.
Journal of Hematology & Oncology|December 19, 2024
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Journal of Hematology & Oncology|January 25, 2025
Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myelomaDirk Hose, Seemun Ray, Sina Rößler, et al.
Nature Communications|November 25, 2024
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pocketsMartin P Schwalm, Johannes Dopfer, Adarsh Kumar, et al.
Cell Chemical Biology|November 28, 2017
Quantitative, Wide-Spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target EngagementJames D Vasta, Cesear R Corona, Jennifer Wilkinson, et al.
Elife|April 21, 2018
Donated chemical probes for open scienceSusanne Müller, Suzanne Ackloo, Cheryl H Arrowsmith, et al.
Pageof 11